

Can't find Invokamet at your pharmacy? Here are proven tools and tips to locate Invokamet in stock near you in 2026, including Medfinder and more.
When your doctor prescribes Invokamet for your type 2 diabetes, you expect to walk into a pharmacy and pick it up. But for many patients, that's not how it goes. Invokamet — a combination of Canagliflozin and Metformin — is a brand-name medication that not every pharmacy stocks. And when you're managing diabetes, going days without your medication isn't an option.
The good news? With the right approach, you can find Invokamet in stock without spending hours on the phone. Here are three proven strategies that work in 2026.
The fastest way to find Invokamet in stock is to use Medfinder. Instead of calling pharmacy after pharmacy, Medfinder lets you search for your medication and see which pharmacies near you have it available — all in one place.
Here's how it works:
This is especially helpful for Invokamet because, as a brand-name combination medication costing $575 to $800 per month at retail, many pharmacies simply don't keep it on their shelves. Medfinder takes the guesswork out of the process.
When chain pharmacies like CVS and Walgreens don't have your medication, independent pharmacies can be a lifesaver. Here's why:
Specialty pharmacies that focus on diabetes or endocrine medications are another great option. They're more likely to stock SGLT2 inhibitor combinations like Invokamet, Synjardy, and Xigduo XR.
Timing matters when it comes to filling brand-name prescriptions. Here are some practical tips:
If none of these strategies work, you still have options:
Many insurance plans offer mail-order pharmacy benefits that can deliver Invokamet directly to your door. You typically get a 90-day supply at a lower cost than three separate 30-day fills at a retail pharmacy. This also eliminates the in-stock guessing game entirely.
Invokamet combines Canagliflozin (sold separately as Invokana) and Metformin into one tablet. If you can't find the combination, your doctor can prescribe the two medications separately. Generic Metformin is widely available for as little as $4 per month, though Invokana is still brand-only.
If Invokamet is consistently unavailable, your doctor might recommend switching to a similar SGLT2 inhibitor/Metformin combination. Options include:
Learn more in our detailed guide to Invokamet alternatives.
Sometimes the issue isn't availability but cost. If high copays are making it hard to fill your prescription, the Janssen CarePath Savings Program may let you pay $0 per month with commercial insurance. Read our full breakdown on how to save money on Invokamet.
If you prefer to call pharmacies directly, here's a script that works:
"Hi, I'm checking to see if you have Invokamet [your strength, e.g., 150/1000 mg] in stock. If not, how long would it take to order? And do you carry it regularly?"
This tells you three important things: whether they have it now, how quickly they can get it, and whether they're likely to have it for future refills. For more tips on checking inventory, see our guide on how to check if a pharmacy has Invokamet in stock.
Finding Invokamet in stock takes a bit of effort, but it doesn't have to be a monthly ordeal. Use Medfinder to check multiple pharmacies at once, build a relationship with an independent pharmacy that will order it for you, and always refill early to give yourself a buffer.
Managing type 2 diabetes is hard enough without pharmacy availability adding to your stress. With the right tools and a little planning, you can keep your medication supply steady and your blood sugar under control.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.